Bionetics Ltd - Period Ending 2022-03-31

Bionetics Ltd - Period Ending 2022-03-31


Bionetics Ltd 05290766 false 2021-04-01 2022-03-31 2022-03-31 The principal activity of the company is the provision of alternative health services. Digita Accounts Production Advanced 6.30.9574.0 true 05290766 2021-04-01 2022-03-31 05290766 2022-03-31 05290766 bus:OrdinaryShareClass1 2022-03-31 05290766 core:CurrentFinancialInstruments 2022-03-31 05290766 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 05290766 core:Non-currentFinancialInstruments core:AfterOneYear 2022-03-31 05290766 core:OtherResidualIntangibleAssets 2022-03-31 05290766 core:FurnitureFittings 2022-03-31 05290766 core:LandBuildings core:ShortLeaseholdAssets 2022-03-31 05290766 core:OfficeEquipment 2022-03-31 05290766 core:PlantMachinery 2022-03-31 05290766 bus:SmallEntities 2021-04-01 2022-03-31 05290766 bus:AuditExemptWithAccountantsReport 2021-04-01 2022-03-31 05290766 bus:FullAccounts 2021-04-01 2022-03-31 05290766 bus:SmallCompaniesRegimeForAccounts 2021-04-01 2022-03-31 05290766 bus:RegisteredOffice 2021-04-01 2022-03-31 05290766 bus:Director1 2021-04-01 2022-03-31 05290766 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 05290766 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 05290766 core:ComputerSoftware 2021-04-01 2022-03-31 05290766 core:Buildings 2021-04-01 2022-03-31 05290766 core:ComputerEquipment 2021-04-01 2022-03-31 05290766 core:FurnitureFittings 2021-04-01 2022-03-31 05290766 core:FurnitureFittingsToolsEquipment 2021-04-01 2022-03-31 05290766 core:LandBuildings core:ShortLeaseholdAssets 2021-04-01 2022-03-31 05290766 core:OfficeEquipment 2021-04-01 2022-03-31 05290766 core:PlantMachinery 2021-04-01 2022-03-31 05290766 countries:England 2021-04-01 2022-03-31 05290766 2021-03-31 05290766 core:OtherResidualIntangibleAssets 2021-03-31 05290766 core:FurnitureFittings 2021-03-31 05290766 core:LandBuildings core:ShortLeaseholdAssets 2021-03-31 05290766 core:OfficeEquipment 2021-03-31 05290766 core:PlantMachinery 2021-03-31 05290766 2020-04-01 2021-03-31 05290766 2021-03-31 05290766 bus:OrdinaryShareClass1 2021-03-31 05290766 core:CurrentFinancialInstruments 2021-03-31 05290766 core:CurrentFinancialInstruments core:WithinOneYear 2021-03-31 05290766 core:Non-currentFinancialInstruments core:AfterOneYear 2021-03-31 05290766 core:FurnitureFittings 2021-03-31 05290766 core:LandBuildings core:ShortLeaseholdAssets 2021-03-31 05290766 core:OfficeEquipment 2021-03-31 05290766 core:PlantMachinery 2021-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05290766

Bionetics Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2022

 

Bionetics Ltd

Contents

Company Information

1

Statement of financial position

2

Notes to the Unaudited Financial Statements

3 to 8

 

Bionetics Ltd

Company Information

Director

Mrs A Pilkington

Registered office

Bryony Cottage
High Street
Fincham
Norfolk
PE33 9EL

Accountants

Hayhow & Co
Chartered Certified Accountants & Business Advisers
19 King Street
King's Lynn
Norfolk
PE30 1HB

 

Bionetics Ltd

(Registration number: 05290766)
Statement of financial position as at 31 March 2022

Note

2022
£

2021
£

Fixed assets

 

Tangible assets

5

5,784

5,063

Current assets

 

Debtors

6

1,460

752

Cash at bank and in hand

 

30,933

32,865

 

32,393

33,617

Creditors: Amounts falling due within one year

7

(8,071)

(2,252)

Net current assets

 

24,322

31,365

Total assets less current liabilities

 

30,106

36,428

Creditors: Amounts falling due after more than one year

7

(28,000)

(28,000)

Net assets

 

2,106

8,428

Capital and reserves

 

Called up share capital

8

1,000

1,000

Retained earnings

1,106

7,428

Shareholders' funds

 

2,106

8,428

For the financial year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Statement of comprehensive income has been taken.

Approved and authorised by the director on 21 November 2022
 

.........................................
Mrs A Pilkington
Director

 

Bionetics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Bryony Cottage
High Street
Fincham
Norfolk
PE33 9EL

These financial statements were authorised for issue by the director on 21 November 2022.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer Equipment

25% straight line

Furniture, Fixtures and Equipment

Fully depreciated

 

Bionetics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

Office Equipment

Fully depreciated

Outbuilding

10% Straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Website development

Fully depreciated

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the statement of comprehensive income over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Bionetics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2021 - 2).

 

Bionetics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

4

Intangible assets

Other intangible assets
 £

Total
£

Cost or valuation

At 1 April 2021

14,883

14,883

At 31 March 2022

14,883

14,883

Amortisation

At 1 April 2021

14,883

14,883

At 31 March 2022

14,883

14,883

Carrying amount

At 31 March 2022

-

-

5

Tangible assets

Short leasehold land and buildings
£

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Cost or valuation

At 1 April 2021

5,503

11,476

5,415

5,235

Additions

1,044

-

442

-

At 31 March 2022

6,547

11,476

5,857

5,235

Depreciation

At 1 April 2021

440

11,476

5,415

5,235

Charge for the year

655

-

110

-

At 31 March 2022

1,095

11,476

5,525

5,235

Carrying amount

At 31 March 2022

5,452

-

332

-

At 31 March 2021

5,063

-

-

-

 

Bionetics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

Total
£

Cost or valuation

At 1 April 2021

27,629

Additions

1,486

At 31 March 2022

29,115

Depreciation

At 1 April 2021

22,566

Charge for the year

765

At 31 March 2022

23,331

Carrying amount

At 31 March 2022

5,784

At 31 March 2021

5,063

 

Bionetics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2022

6

Debtors

Current

2022
£

2021
£

Trade debtors

509

-

Other debtors

951

752

 

1,460

752

7

Creditors

Creditors: amounts falling due within one year

Note

2022
£

2021
£

Due within one year

 

Bank loans and overdrafts

176

-

trade creditors

 

5,662

483

Taxation and social security

 

1,172

790

Accruals and deferred income

 

1,061

979

 

8,071

2,252

Creditors: amounts falling due after more than one year

Note

2022
£

2021
£

Due after one year

 

Loans and borrowings

28,000

28,000

8

Share capital

Allotted, called up and fully paid shares

 

2022

2021

 

No.

£

No.

£

Ordinary of £1 each

1,000

1,000

1,000

1,000

         

Each share is entitled to one vote in any circumstances and each share is also entitled pari passu to dividend payments or any other distribution, including a distribution arising from a winding up of the company.